TY - JOUR
T1 - Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation
AU - Horak, D. A.
AU - Schmidt, G. M.
AU - Zaia, J. A.
AU - Niland, J. C.
AU - Ahn, C.
AU - Forman, S. J.
PY - 1992
Y1 - 1992
N2 - Study Objective: To determine the value of pulmonary function tests (PFTs) in predicting the development of human cytomegalovirus (CMV)-associated interstitial pneumonia (IP) in allogeneic bone marrow transplant (BMT) recipients. Design: Nonrandomized, prospective, open-trial study. Setting: Tertiary referral medical center. Patients: 66 evaluable CMV-seropositive patients with hematologic malignancies who were undergoing allogeneic BMT. Intervention: FEV1, FVC, FEV1/FVC, TLC, Dco(c)/VA, PaO2, and P(A-a)O2 were measured on days -13, +33, and +44 following BMT. CMV-IP was diagnosed when typical roentgenographic findings developed with confirmatory positive bronchoalveolar lavage (BAL) using standard cytologic and/or rapid culture techniques. Measurement and Main Results: Univariate logistic regression analysis to predict the development of CMV-IP revealed significant associations with the day -13 and +33 percent predicted FEV1, FVC, and TLC (p<0.01) but no associations with other PFT parameters or with changes in these parameters. Stepwise logistic regression analysis demonstrated that only BAL positivity for CMV (odds ratio 14.8; p = 0.0002) and day -13 percent predicted FEV1 (odds ratio 0.92; p = 0.0004) were significant independent predictors of CMV-IP. Conclusion: Pretransplant lung function is a previously unrecognized strong predictor and risk factor for the subsequent development of CMV-IP in BMT recipients.
AB - Study Objective: To determine the value of pulmonary function tests (PFTs) in predicting the development of human cytomegalovirus (CMV)-associated interstitial pneumonia (IP) in allogeneic bone marrow transplant (BMT) recipients. Design: Nonrandomized, prospective, open-trial study. Setting: Tertiary referral medical center. Patients: 66 evaluable CMV-seropositive patients with hematologic malignancies who were undergoing allogeneic BMT. Intervention: FEV1, FVC, FEV1/FVC, TLC, Dco(c)/VA, PaO2, and P(A-a)O2 were measured on days -13, +33, and +44 following BMT. CMV-IP was diagnosed when typical roentgenographic findings developed with confirmatory positive bronchoalveolar lavage (BAL) using standard cytologic and/or rapid culture techniques. Measurement and Main Results: Univariate logistic regression analysis to predict the development of CMV-IP revealed significant associations with the day -13 and +33 percent predicted FEV1, FVC, and TLC (p<0.01) but no associations with other PFT parameters or with changes in these parameters. Stepwise logistic regression analysis demonstrated that only BAL positivity for CMV (odds ratio 14.8; p = 0.0002) and day -13 percent predicted FEV1 (odds ratio 0.92; p = 0.0004) were significant independent predictors of CMV-IP. Conclusion: Pretransplant lung function is a previously unrecognized strong predictor and risk factor for the subsequent development of CMV-IP in BMT recipients.
UR - http://www.scopus.com/inward/record.url?scp=0026446259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026446259&partnerID=8YFLogxK
U2 - 10.1378/chest.102.5.1484
DO - 10.1378/chest.102.5.1484
M3 - Article
C2 - 1330449
AN - SCOPUS:0026446259
SN - 0012-3692
VL - 102
SP - 1484
EP - 1490
JO - CHEST
JF - CHEST
IS - 5
ER -